nodes	percent_of_prediction	percent_of_DWPC	metapath
Emedastine—Olanzapine—CHRM3—epilepsy syndrome	0.00462	0.172	CrCbGaD
Emedastine—Olanzapine—CHRM1—epilepsy syndrome	0.00431	0.161	CrCbGaD
Emedastine—Olanzapine—CHRM2—epilepsy syndrome	0.00352	0.131	CrCbGaD
Emedastine—Olanzapine—HTR7—epilepsy syndrome	0.0035	0.13	CrCbGaD
Emedastine—Olanzapine—ADRA2A—epilepsy syndrome	0.00301	0.112	CrCbGaD
Emedastine—Sinusitis—Lamotrigine—epilepsy syndrome	0.00245	0.00296	CcSEcCtD
Emedastine—Asthenia—Trimethadione—epilepsy syndrome	0.00244	0.00294	CcSEcCtD
Emedastine—Rhinitis—Carbamazepine—epilepsy syndrome	0.00244	0.00294	CcSEcCtD
Emedastine—Rash—Primidone—epilepsy syndrome	0.00244	0.00294	CcSEcCtD
Emedastine—Dermatitis—Primidone—epilepsy syndrome	0.00243	0.00294	CcSEcCtD
Emedastine—Headache—Primidone—epilepsy syndrome	0.00242	0.00292	CcSEcCtD
Emedastine—Pruritus—Trimethadione—epilepsy syndrome	0.0024	0.0029	CcSEcCtD
Emedastine—Eye disorder—Clonazepam—epilepsy syndrome	0.00239	0.00289	CcSEcCtD
Emedastine—Dry eye—Topiramate—epilepsy syndrome	0.00239	0.00289	CcSEcCtD
Emedastine—Dysgeusia—Diazepam—epilepsy syndrome	0.00239	0.00289	CcSEcCtD
Emedastine—Cardiac disorder—Clonazepam—epilepsy syndrome	0.00238	0.00287	CcSEcCtD
Emedastine—Eye disorder—Oxcarbazepine—epilepsy syndrome	0.00237	0.00286	CcSEcCtD
Emedastine—Rhinitis—Lamotrigine—epilepsy syndrome	0.00235	0.00284	CcSEcCtD
Emedastine—Cardiac disorder—Oxcarbazepine—epilepsy syndrome	0.00235	0.00284	CcSEcCtD
Emedastine—Vision blurred—Vigabatrin—epilepsy syndrome	0.00234	0.00282	CcSEcCtD
Emedastine—Mental disorder—Zonisamide—epilepsy syndrome	0.00233	0.00281	CcSEcCtD
Emedastine—Dysgeusia—Felbamate—epilepsy syndrome	0.00232	0.00279	CcSEcCtD
Emedastine—Vision blurred—Diazepam—epilepsy syndrome	0.0023	0.00278	CcSEcCtD
Emedastine—Eye disorder—Carbamazepine—epilepsy syndrome	0.00227	0.00274	CcSEcCtD
Emedastine—Dysgeusia—Zonisamide—epilepsy syndrome	0.00227	0.00274	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Midazolam—epilepsy syndrome	0.00226	0.00273	CcSEcCtD
Emedastine—Cardiac disorder—Carbamazepine—epilepsy syndrome	0.00226	0.00272	CcSEcCtD
Emedastine—Mental disorder—Clonazepam—epilepsy syndrome	0.00225	0.00271	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Levetiracetam—epilepsy syndrome	0.00223	0.00269	CcSEcCtD
Emedastine—Mental disorder—Oxcarbazepine—epilepsy syndrome	0.00222	0.00268	CcSEcCtD
Emedastine—Eye disorder—Lamotrigine—epilepsy syndrome	0.00219	0.00265	CcSEcCtD
Emedastine—Tachycardia—Propofol—epilepsy syndrome	0.00217	0.00262	CcSEcCtD
Emedastine—Olanzapine—CYP2C19—epilepsy syndrome	0.00217	0.0809	CrCbGaD
Emedastine—Dysgeusia—Phenytoin—epilepsy syndrome	0.00217	0.00262	CcSEcCtD
Emedastine—Dysgeusia—Oxcarbazepine—epilepsy syndrome	0.00216	0.0026	CcSEcCtD
Emedastine—Rash—Trimethadione—epilepsy syndrome	0.00214	0.00259	CcSEcCtD
Emedastine—Discomfort—Fosphenytoin—epilepsy syndrome	0.00214	0.00258	CcSEcCtD
Emedastine—Dermatitis—Trimethadione—epilepsy syndrome	0.00214	0.00258	CcSEcCtD
Emedastine—Nervous system disorder—Midazolam—epilepsy syndrome	0.00214	0.00258	CcSEcCtD
Emedastine—Mental disorder—Carbamazepine—epilepsy syndrome	0.00213	0.00257	CcSEcCtD
Emedastine—Headache—Trimethadione—epilepsy syndrome	0.00213	0.00257	CcSEcCtD
Emedastine—Tachycardia—Midazolam—epilepsy syndrome	0.00213	0.00257	CcSEcCtD
Emedastine—Asthenia—Rufinamide—epilepsy syndrome	0.00212	0.00256	CcSEcCtD
Emedastine—Skin disorder—Midazolam—epilepsy syndrome	0.00212	0.00256	CcSEcCtD
Emedastine—Nervous system disorder—Levetiracetam—epilepsy syndrome	0.00211	0.00255	CcSEcCtD
Emedastine—Vision blurred—Clonazepam—epilepsy syndrome	0.0021	0.00254	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Vigabatrin—epilepsy syndrome	0.0021	0.00253	CcSEcCtD
Emedastine—Skin disorder—Levetiracetam—epilepsy syndrome	0.00209	0.00252	CcSEcCtD
Emedastine—Pruritus—Rufinamide—epilepsy syndrome	0.00209	0.00252	CcSEcCtD
Emedastine—Discomfort—Vigabatrin—epilepsy syndrome	0.00209	0.00252	CcSEcCtD
Emedastine—Eye pain—Topiramate—epilepsy syndrome	0.00208	0.00251	CcSEcCtD
Emedastine—Vision blurred—Oxcarbazepine—epilepsy syndrome	0.00208	0.00251	CcSEcCtD
Emedastine—Dysgeusia—Carbamazepine—epilepsy syndrome	0.00207	0.0025	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Diazepam—epilepsy syndrome	0.00207	0.00249	CcSEcCtD
Emedastine—Mental disorder—Lamotrigine—epilepsy syndrome	0.00206	0.00248	CcSEcCtD
Emedastine—Discomfort—Diazepam—epilepsy syndrome	0.00206	0.00248	CcSEcCtD
Emedastine—Tachycardia—Fosphenytoin—epilepsy syndrome	0.00203	0.00245	CcSEcCtD
Emedastine—Dysgeusia—Lamotrigine—epilepsy syndrome	0.002	0.00242	CcSEcCtD
Emedastine—Vision blurred—Carbamazepine—epilepsy syndrome	0.00199	0.00241	CcSEcCtD
Emedastine—Asthenia—Lacosamide—epilepsy syndrome	0.00199	0.0024	CcSEcCtD
Emedastine—Discomfort—Felbamate—epilepsy syndrome	0.00199	0.0024	CcSEcCtD
Emedastine—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.00199	0.0024	CcSEcCtD
Emedastine—Skin disorder—Vigabatrin—epilepsy syndrome	0.00197	0.00237	CcSEcCtD
Emedastine—Pruritus—Lacosamide—epilepsy syndrome	0.00196	0.00237	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Zonisamide—epilepsy syndrome	0.00196	0.00236	CcSEcCtD
Emedastine—Nervous system disorder—Diazepam—epilepsy syndrome	0.00196	0.00236	CcSEcCtD
Emedastine—Sinusitis—Valproic Acid—epilepsy syndrome	0.00195	0.00235	CcSEcCtD
Emedastine—Discomfort—Zonisamide—epilepsy syndrome	0.00195	0.00235	CcSEcCtD
Emedastine—Tachycardia—Diazepam—epilepsy syndrome	0.00195	0.00235	CcSEcCtD
Emedastine—Skin disorder—Diazepam—epilepsy syndrome	0.00194	0.00234	CcSEcCtD
Emedastine—Asthenia—Clobazam—epilepsy syndrome	0.00193	0.00233	CcSEcCtD
Emedastine—Vision blurred—Lamotrigine—epilepsy syndrome	0.00193	0.00232	CcSEcCtD
Emedastine—Pain—Propofol—epilepsy syndrome	0.00191	0.0023	CcSEcCtD
Emedastine—Pruritus—Clobazam—epilepsy syndrome	0.0019	0.0023	CcSEcCtD
Emedastine—Rash—Phenobarbital—epilepsy syndrome	0.0019	0.00229	CcSEcCtD
Emedastine—Dermatitis—Phenobarbital—epilepsy syndrome	0.0019	0.00229	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Clonazepam—epilepsy syndrome	0.00189	0.00228	CcSEcCtD
Emedastine—Headache—Phenobarbital—epilepsy syndrome	0.00189	0.00227	CcSEcCtD
Emedastine—Tachycardia—Felbamate—epilepsy syndrome	0.00188	0.00227	CcSEcCtD
Emedastine—Discomfort—Clonazepam—epilepsy syndrome	0.00188	0.00226	CcSEcCtD
Emedastine—Rhinitis—Valproic Acid—epilepsy syndrome	0.00187	0.00226	CcSEcCtD
Emedastine—Pain—Midazolam—epilepsy syndrome	0.00186	0.00225	CcSEcCtD
Emedastine—Discomfort—Phenytoin—epilepsy syndrome	0.00186	0.00225	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Oxcarbazepine—epilepsy syndrome	0.00186	0.00225	CcSEcCtD
Emedastine—Rash—Rufinamide—epilepsy syndrome	0.00186	0.00225	CcSEcCtD
Emedastine—Dermatitis—Rufinamide—epilepsy syndrome	0.00186	0.00225	CcSEcCtD
Emedastine—Discomfort—Oxcarbazepine—epilepsy syndrome	0.00185	0.00224	CcSEcCtD
Emedastine—Nervous system disorder—Zonisamide—epilepsy syndrome	0.00185	0.00224	CcSEcCtD
Emedastine—Headache—Rufinamide—epilepsy syndrome	0.00185	0.00223	CcSEcCtD
Emedastine—Tachycardia—Zonisamide—epilepsy syndrome	0.00184	0.00222	CcSEcCtD
Emedastine—Pain—Levetiracetam—epilepsy syndrome	0.00184	0.00222	CcSEcCtD
Emedastine—Skin disorder—Zonisamide—epilepsy syndrome	0.00184	0.00221	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Carbamazepine—epilepsy syndrome	0.00179	0.00216	CcSEcCtD
Emedastine—Nervous system disorder—Clonazepam—epilepsy syndrome	0.00179	0.00215	CcSEcCtD
Emedastine—Tachycardia—Clonazepam—epilepsy syndrome	0.00178	0.00214	CcSEcCtD
Emedastine—Nervous system disorder—Phenytoin—epilepsy syndrome	0.00177	0.00214	CcSEcCtD
Emedastine—Skin disorder—Clonazepam—epilepsy syndrome	0.00177	0.00213	CcSEcCtD
Emedastine—Tachycardia—Phenytoin—epilepsy syndrome	0.00177	0.00213	CcSEcCtD
Emedastine—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.00176	0.00213	CcSEcCtD
Emedastine—Sinusitis—Pregabalin—epilepsy syndrome	0.00176	0.00213	CcSEcCtD
Emedastine—Olanzapine—HTR2A—epilepsy syndrome	0.00176	0.0656	CrCbGaD
Emedastine—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.00176	0.00212	CcSEcCtD
Emedastine—Rash—Lacosamide—epilepsy syndrome	0.00175	0.00211	CcSEcCtD
Emedastine—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.00175	0.00211	CcSEcCtD
Emedastine—Dermatitis—Lacosamide—epilepsy syndrome	0.00175	0.00211	CcSEcCtD
Emedastine—Eye disorder—Valproic Acid—epilepsy syndrome	0.00174	0.0021	CcSEcCtD
Emedastine—Headache—Lacosamide—epilepsy syndrome	0.00174	0.0021	CcSEcCtD
Emedastine—Pain—Vigabatrin—epilepsy syndrome	0.00173	0.00209	CcSEcCtD
Emedastine—Asthenia—Acetazolamide—epilepsy syndrome	0.00172	0.00208	CcSEcCtD
Emedastine—Discomfort—Lamotrigine—epilepsy syndrome	0.00172	0.00208	CcSEcCtD
Emedastine—Pain—Diazepam—epilepsy syndrome	0.00171	0.00206	CcSEcCtD
Emedastine—Rash—Clobazam—epilepsy syndrome	0.0017	0.00205	CcSEcCtD
Emedastine—Dermatitis—Clobazam—epilepsy syndrome	0.0017	0.00205	CcSEcCtD
Emedastine—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.00169	0.00204	CcSEcCtD
Emedastine—Rhinitis—Pregabalin—epilepsy syndrome	0.00169	0.00204	CcSEcCtD
Emedastine—Headache—Clobazam—epilepsy syndrome	0.00169	0.00203	CcSEcCtD
Emedastine—Tachycardia—Carbamazepine—epilepsy syndrome	0.00168	0.00203	CcSEcCtD
Emedastine—Skin disorder—Carbamazepine—epilepsy syndrome	0.00168	0.00202	CcSEcCtD
Emedastine—Pain—Felbamate—epilepsy syndrome	0.00165	0.00199	CcSEcCtD
Emedastine—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.00164	0.00197	CcSEcCtD
Emedastine—Mental disorder—Valproic Acid—epilepsy syndrome	0.00163	0.00197	CcSEcCtD
Emedastine—Tachycardia—Lamotrigine—epilepsy syndrome	0.00163	0.00196	CcSEcCtD
Emedastine—Sinusitis—Gabapentin—epilepsy syndrome	0.00162	0.00195	CcSEcCtD
Emedastine—Olanzapine—CYP2D6—epilepsy syndrome	0.00161	0.06	CrCbGaD
Emedastine—Asthenia—Propofol—epilepsy syndrome	0.0016	0.00193	CcSEcCtD
Emedastine—Dysgeusia—Valproic Acid—epilepsy syndrome	0.00159	0.00192	CcSEcCtD
Emedastine—Pruritus—Propofol—epilepsy syndrome	0.00158	0.0019	CcSEcCtD
Emedastine—Eye disorder—Pregabalin—epilepsy syndrome	0.00158	0.0019	CcSEcCtD
Emedastine—Cardiac disorder—Pregabalin—epilepsy syndrome	0.00157	0.00189	CcSEcCtD
Emedastine—Asthenia—Midazolam—epilepsy syndrome	0.00156	0.00189	CcSEcCtD
Emedastine—Pain—Clonazepam—epilepsy syndrome	0.00156	0.00188	CcSEcCtD
Emedastine—Rhinitis—Gabapentin—epilepsy syndrome	0.00155	0.00187	CcSEcCtD
Emedastine—Asthenia—Levetiracetam—epilepsy syndrome	0.00154	0.00186	CcSEcCtD
Emedastine—Pruritus—Midazolam—epilepsy syndrome	0.00154	0.00186	CcSEcCtD
Emedastine—Pain—Oxcarbazepine—epilepsy syndrome	0.00154	0.00186	CcSEcCtD
Emedastine—Vision blurred—Valproic Acid—epilepsy syndrome	0.00153	0.00185	CcSEcCtD
Emedastine—Pruritus—Levetiracetam—epilepsy syndrome	0.00152	0.00184	CcSEcCtD
Emedastine—Headache—Acetazolamide—epilepsy syndrome	0.0015	0.00181	CcSEcCtD
Emedastine—Asthenia—Fosphenytoin—epilepsy syndrome	0.00149	0.0018	CcSEcCtD
Emedastine—Mental disorder—Pregabalin—epilepsy syndrome	0.00148	0.00178	CcSEcCtD
Emedastine—Pain—Carbamazepine—epilepsy syndrome	0.00148	0.00178	CcSEcCtD
Emedastine—Pruritus—Fosphenytoin—epilepsy syndrome	0.00147	0.00177	CcSEcCtD
Emedastine—Asthenia—Vigabatrin—epilepsy syndrome	0.00145	0.00175	CcSEcCtD
Emedastine—Eye disorder—Gabapentin—epilepsy syndrome	0.00145	0.00174	CcSEcCtD
Emedastine—Dysgeusia—Pregabalin—epilepsy syndrome	0.00144	0.00174	CcSEcCtD
Emedastine—Cardiac disorder—Gabapentin—epilepsy syndrome	0.00144	0.00173	CcSEcCtD
Emedastine—Pruritus—Vigabatrin—epilepsy syndrome	0.00143	0.00173	CcSEcCtD
Emedastine—Asthenia—Diazepam—epilepsy syndrome	0.00143	0.00173	CcSEcCtD
Emedastine—Pain—Lamotrigine—epilepsy syndrome	0.00143	0.00172	CcSEcCtD
Emedastine—Pruritus—Diazepam—epilepsy syndrome	0.00141	0.0017	CcSEcCtD
Emedastine—Rash—Propofol—epilepsy syndrome	0.00141	0.0017	CcSEcCtD
Emedastine—Dermatitis—Propofol—epilepsy syndrome	0.0014	0.00169	CcSEcCtD
Emedastine—Headache—Propofol—epilepsy syndrome	0.0014	0.00168	CcSEcCtD
Emedastine—Asthenia—Felbamate—epilepsy syndrome	0.00138	0.00167	CcSEcCtD
Emedastine—Vision blurred—Pregabalin—epilepsy syndrome	0.00138	0.00167	CcSEcCtD
Emedastine—Rash—Midazolam—epilepsy syndrome	0.00137	0.00166	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.00137	0.00166	CcSEcCtD
Emedastine—Dermatitis—Midazolam—epilepsy syndrome	0.00137	0.00166	CcSEcCtD
Emedastine—Discomfort—Valproic Acid—epilepsy syndrome	0.00137	0.00165	CcSEcCtD
Emedastine—Headache—Midazolam—epilepsy syndrome	0.00137	0.00165	CcSEcCtD
Emedastine—Pruritus—Felbamate—epilepsy syndrome	0.00137	0.00165	CcSEcCtD
Emedastine—Sinusitis—Topiramate—epilepsy syndrome	0.00136	0.00164	CcSEcCtD
Emedastine—Rash—Levetiracetam—epilepsy syndrome	0.00136	0.00164	CcSEcCtD
Emedastine—Dermatitis—Levetiracetam—epilepsy syndrome	0.00136	0.00164	CcSEcCtD
Emedastine—Asthenia—Zonisamide—epilepsy syndrome	0.00136	0.00164	CcSEcCtD
Emedastine—Mental disorder—Gabapentin—epilepsy syndrome	0.00136	0.00164	CcSEcCtD
Emedastine—Headache—Levetiracetam—epilepsy syndrome	0.00135	0.00163	CcSEcCtD
Emedastine—Pruritus—Zonisamide—epilepsy syndrome	0.00134	0.00161	CcSEcCtD
Emedastine—Dysgeusia—Gabapentin—epilepsy syndrome	0.00132	0.00159	CcSEcCtD
Emedastine—Rash—Fosphenytoin—epilepsy syndrome	0.00131	0.00158	CcSEcCtD
Emedastine—Dermatitis—Fosphenytoin—epilepsy syndrome	0.00131	0.00158	CcSEcCtD
Emedastine—Asthenia—Clonazepam—epilepsy syndrome	0.00131	0.00158	CcSEcCtD
Emedastine—Rhinitis—Topiramate—epilepsy syndrome	0.0013	0.00157	CcSEcCtD
Emedastine—Headache—Fosphenytoin—epilepsy syndrome	0.0013	0.00157	CcSEcCtD
Emedastine—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.0013	0.00157	CcSEcCtD
Emedastine—Asthenia—Phenytoin—epilepsy syndrome	0.0013	0.00157	CcSEcCtD
Emedastine—Tachycardia—Valproic Acid—epilepsy syndrome	0.00129	0.00156	CcSEcCtD
Emedastine—Asthenia—Oxcarbazepine—epilepsy syndrome	0.00129	0.00156	CcSEcCtD
Emedastine—Pruritus—Clonazepam—epilepsy syndrome	0.00129	0.00155	CcSEcCtD
Emedastine—Skin disorder—Valproic Acid—epilepsy syndrome	0.00129	0.00155	CcSEcCtD
Emedastine—Pruritus—Phenytoin—epilepsy syndrome	0.00128	0.00154	CcSEcCtD
Emedastine—Rash—Vigabatrin—epilepsy syndrome	0.00128	0.00154	CcSEcCtD
Emedastine—Dermatitis—Vigabatrin—epilepsy syndrome	0.00128	0.00154	CcSEcCtD
Emedastine—Pruritus—Oxcarbazepine—epilepsy syndrome	0.00127	0.00154	CcSEcCtD
Emedastine—Vision blurred—Gabapentin—epilepsy syndrome	0.00127	0.00153	CcSEcCtD
Emedastine—Headache—Vigabatrin—epilepsy syndrome	0.00127	0.00153	CcSEcCtD
Emedastine—Rash—Diazepam—epilepsy syndrome	0.00126	0.00152	CcSEcCtD
Emedastine—Dermatitis—Diazepam—epilepsy syndrome	0.00126	0.00152	CcSEcCtD
Emedastine—Headache—Diazepam—epilepsy syndrome	0.00125	0.00151	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.00124	0.0015	CcSEcCtD
Emedastine—Asthenia—Carbamazepine—epilepsy syndrome	0.00124	0.00149	CcSEcCtD
Emedastine—Discomfort—Pregabalin—epilepsy syndrome	0.00124	0.00149	CcSEcCtD
Emedastine—Pruritus—Carbamazepine—epilepsy syndrome	0.00122	0.00147	CcSEcCtD
Emedastine—Rash—Felbamate—epilepsy syndrome	0.00122	0.00147	CcSEcCtD
Emedastine—Eye disorder—Topiramate—epilepsy syndrome	0.00122	0.00147	CcSEcCtD
Emedastine—Dermatitis—Felbamate—epilepsy syndrome	0.00122	0.00147	CcSEcCtD
Emedastine—Headache—Felbamate—epilepsy syndrome	0.00121	0.00146	CcSEcCtD
Emedastine—Cardiac disorder—Topiramate—epilepsy syndrome	0.00121	0.00146	CcSEcCtD
Emedastine—Olanzapine—ALB—epilepsy syndrome	0.00121	0.0449	CrCbGaD
Emedastine—Asthenia—Lamotrigine—epilepsy syndrome	0.0012	0.00144	CcSEcCtD
Emedastine—Rash—Zonisamide—epilepsy syndrome	0.00119	0.00144	CcSEcCtD
Emedastine—Dermatitis—Zonisamide—epilepsy syndrome	0.00119	0.00144	CcSEcCtD
Emedastine—Headache—Zonisamide—epilepsy syndrome	0.00118	0.00143	CcSEcCtD
Emedastine—Pruritus—Lamotrigine—epilepsy syndrome	0.00118	0.00142	CcSEcCtD
Emedastine—Nervous system disorder—Pregabalin—epilepsy syndrome	0.00118	0.00142	CcSEcCtD
Emedastine—Tachycardia—Pregabalin—epilepsy syndrome	0.00117	0.00141	CcSEcCtD
Emedastine—Skin disorder—Pregabalin—epilepsy syndrome	0.00116	0.0014	CcSEcCtD
Emedastine—Olanzapine—ABCB1—epilepsy syndrome	0.00115	0.0428	CrCbGaD
Emedastine—Rash—Clonazepam—epilepsy syndrome	0.00115	0.00139	CcSEcCtD
Emedastine—Dermatitis—Clonazepam—epilepsy syndrome	0.00115	0.00138	CcSEcCtD
Emedastine—Headache—Clonazepam—epilepsy syndrome	0.00114	0.00138	CcSEcCtD
Emedastine—Rash—Phenytoin—epilepsy syndrome	0.00114	0.00138	CcSEcCtD
Emedastine—Mental disorder—Topiramate—epilepsy syndrome	0.00114	0.00138	CcSEcCtD
Emedastine—Dermatitis—Phenytoin—epilepsy syndrome	0.00114	0.00137	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.00114	0.00137	CcSEcCtD
Emedastine—Rash—Oxcarbazepine—epilepsy syndrome	0.00113	0.00137	CcSEcCtD
Emedastine—Pain—Valproic Acid—epilepsy syndrome	0.00113	0.00137	CcSEcCtD
Emedastine—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.00113	0.00137	CcSEcCtD
Emedastine—Headache—Phenytoin—epilepsy syndrome	0.00113	0.00137	CcSEcCtD
Emedastine—Discomfort—Gabapentin—epilepsy syndrome	0.00113	0.00137	CcSEcCtD
Emedastine—Headache—Oxcarbazepine—epilepsy syndrome	0.00113	0.00136	CcSEcCtD
Emedastine—Dysgeusia—Topiramate—epilepsy syndrome	0.00111	0.00134	CcSEcCtD
Emedastine—Rash—Carbamazepine—epilepsy syndrome	0.00109	0.00131	CcSEcCtD
Emedastine—Dermatitis—Carbamazepine—epilepsy syndrome	0.00109	0.00131	CcSEcCtD
Emedastine—Headache—Carbamazepine—epilepsy syndrome	0.00108	0.00131	CcSEcCtD
Emedastine—Nervous system disorder—Gabapentin—epilepsy syndrome	0.00108	0.0013	CcSEcCtD
Emedastine—Tachycardia—Gabapentin—epilepsy syndrome	0.00107	0.00129	CcSEcCtD
Emedastine—Vision blurred—Topiramate—epilepsy syndrome	0.00107	0.00129	CcSEcCtD
Emedastine—Skin disorder—Gabapentin—epilepsy syndrome	0.00107	0.00129	CcSEcCtD
Emedastine—Rash—Lamotrigine—epilepsy syndrome	0.00105	0.00127	CcSEcCtD
Emedastine—Dermatitis—Lamotrigine—epilepsy syndrome	0.00105	0.00127	CcSEcCtD
Emedastine—Headache—Lamotrigine—epilepsy syndrome	0.00105	0.00126	CcSEcCtD
Emedastine—Pain—Pregabalin—epilepsy syndrome	0.00102	0.00124	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000958	0.00116	CcSEcCtD
Emedastine—Discomfort—Topiramate—epilepsy syndrome	0.000953	0.00115	CcSEcCtD
Emedastine—Asthenia—Valproic Acid—epilepsy syndrome	0.000951	0.00115	CcSEcCtD
Emedastine—Pain—Gabapentin—epilepsy syndrome	0.00094	0.00113	CcSEcCtD
Emedastine—Pruritus—Valproic Acid—epilepsy syndrome	0.000938	0.00113	CcSEcCtD
Emedastine—Nervous system disorder—Topiramate—epilepsy syndrome	0.000907	0.00109	CcSEcCtD
Emedastine—Tachycardia—Topiramate—epilepsy syndrome	0.000902	0.00109	CcSEcCtD
Emedastine—Skin disorder—Topiramate—epilepsy syndrome	0.000898	0.00108	CcSEcCtD
Emedastine—Asthenia—Pregabalin—epilepsy syndrome	0.00086	0.00104	CcSEcCtD
Emedastine—Pruritus—Pregabalin—epilepsy syndrome	0.000848	0.00102	CcSEcCtD
Emedastine—Rash—Valproic Acid—epilepsy syndrome	0.000836	0.00101	CcSEcCtD
Emedastine—Dermatitis—Valproic Acid—epilepsy syndrome	0.000835	0.00101	CcSEcCtD
Emedastine—Headache—Valproic Acid—epilepsy syndrome	0.000831	0.001	CcSEcCtD
Emedastine—Pain—Topiramate—epilepsy syndrome	0.000791	0.000954	CcSEcCtD
Emedastine—Asthenia—Gabapentin—epilepsy syndrome	0.000789	0.000952	CcSEcCtD
Emedastine—Pruritus—Gabapentin—epilepsy syndrome	0.000778	0.000938	CcSEcCtD
Emedastine—Rash—Pregabalin—epilepsy syndrome	0.000756	0.000912	CcSEcCtD
Emedastine—Dermatitis—Pregabalin—epilepsy syndrome	0.000755	0.000911	CcSEcCtD
Emedastine—Headache—Pregabalin—epilepsy syndrome	0.000751	0.000906	CcSEcCtD
Emedastine—Rash—Gabapentin—epilepsy syndrome	0.000693	0.000836	CcSEcCtD
Emedastine—Dermatitis—Gabapentin—epilepsy syndrome	0.000692	0.000835	CcSEcCtD
Emedastine—Headache—Gabapentin—epilepsy syndrome	0.000689	0.000831	CcSEcCtD
Emedastine—Asthenia—Topiramate—epilepsy syndrome	0.000663	0.000801	CcSEcCtD
Emedastine—Pruritus—Topiramate—epilepsy syndrome	0.000654	0.000789	CcSEcCtD
Emedastine—Rash—Topiramate—epilepsy syndrome	0.000583	0.000704	CcSEcCtD
Emedastine—Dermatitis—Topiramate—epilepsy syndrome	0.000582	0.000703	CcSEcCtD
Emedastine—Headache—Topiramate—epilepsy syndrome	0.000579	0.000699	CcSEcCtD
Emedastine—HRH1—GPCR ligand binding—CHRM3—epilepsy syndrome	0.000386	0.00267	CbGpPWpGaD
Emedastine—HRH1—GPCRs, Class A Rhodopsin-like—BDKRB2—epilepsy syndrome	0.000385	0.00267	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—ACKR4—epilepsy syndrome	0.000381	0.00264	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—SSTR4—epilepsy syndrome	0.000379	0.00263	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—SSTR5—epilepsy syndrome	0.000379	0.00263	CbGpPWpGaD
Emedastine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—epilepsy syndrome	0.000378	0.00262	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—CX3CR1—epilepsy syndrome	0.00037	0.00256	CbGpPWpGaD
Emedastine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	0.000369	0.00255	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CCR10—epilepsy syndrome	0.000364	0.00252	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—CX3CL1—epilepsy syndrome	0.000363	0.00251	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—BDKRB1—epilepsy syndrome	0.000363	0.00251	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—CHRM2—epilepsy syndrome	0.000363	0.00251	CbGpPWpGaD
Emedastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	0.000359	0.00249	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—GABBR1—epilepsy syndrome	0.000353	0.00244	CbGpPWpGaD
Emedastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	0.000351	0.00243	CbGpPWpGaD
Emedastine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	0.000351	0.00243	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—SSTR5—epilepsy syndrome	0.000345	0.00239	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—SSTR4—epilepsy syndrome	0.000345	0.00239	CbGpPWpGaD
Emedastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	0.000343	0.00238	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—HRH3—epilepsy syndrome	0.000338	0.00234	CbGpPWpGaD
Emedastine—HRH1—G alpha (q) signalling events—HTR2A—epilepsy syndrome	0.000334	0.00231	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—OPRM1—epilepsy syndrome	0.000333	0.0023	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CCR10—epilepsy syndrome	0.00033	0.00229	CbGpPWpGaD
Emedastine—HRH1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	0.00033	0.00228	CbGpPWpGaD
Emedastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	0.00033	0.00228	CbGpPWpGaD
Emedastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	0.000324	0.00224	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—GRM2—epilepsy syndrome	0.000318	0.0022	CbGpPWpGaD
Emedastine—HRH1—G alpha (q) signalling events—AGT—epilepsy syndrome	0.000317	0.0022	CbGpPWpGaD
Emedastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	0.000316	0.00219	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—CCR3—epilepsy syndrome	0.000314	0.00218	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—NPY—epilepsy syndrome	0.000306	0.00212	CbGpPWpGaD
Emedastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	0.000299	0.00207	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—CRH—epilepsy syndrome	0.000296	0.00205	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—OXT—epilepsy syndrome	0.000296	0.00205	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—CXCL2—epilepsy syndrome	0.000296	0.00205	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—CCL3—epilepsy syndrome	0.000296	0.00205	CbGpPWpGaD
Emedastine—HRH1—IL-4 Signaling Pathway—AKT1—epilepsy syndrome	0.000289	0.002	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—GRM2—epilepsy syndrome	0.000289	0.002	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—SSTR3—epilepsy syndrome	0.000288	0.00199	CbGpPWpGaD
Emedastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	0.000284	0.00196	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	0.000276	0.00191	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—NPY2R—epilepsy syndrome	0.000276	0.00191	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CCR9—epilepsy syndrome	0.000276	0.00191	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—SSTR1—epilepsy syndrome	0.000276	0.00191	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CCR8—epilepsy syndrome	0.000276	0.00191	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—GRM4—epilepsy syndrome	0.00027	0.00187	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—GRM3—epilepsy syndrome	0.00027	0.00187	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—SST—epilepsy syndrome	0.000267	0.00185	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—CCR2—epilepsy syndrome	0.000267	0.00185	CbGpPWpGaD
Emedastine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	0.000266	0.00184	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—SSTR2—epilepsy syndrome	0.000265	0.00184	CbGpPWpGaD
Emedastine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	0.000264	0.00183	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.000262	0.00181	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—SSTR3—epilepsy syndrome	0.000261	0.00181	CbGpPWpGaD
Emedastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	0.000261	0.00181	CbGpPWpGaD
Emedastine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	0.000258	0.00179	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000257	0.00178	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—PRDM4—epilepsy syndrome	0.000257	0.00178	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—GRM8—epilepsy syndrome	0.000256	0.00177	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—CXCL12—epilepsy syndrome	0.000251	0.00174	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—BDKRB2—epilepsy syndrome	0.000251	0.00174	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.00025	0.00173	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CCR9—epilepsy syndrome	0.00025	0.00173	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—NPY2R—epilepsy syndrome	0.00025	0.00173	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—SSTR1—epilepsy syndrome	0.00025	0.00173	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CCR8—epilepsy syndrome	0.00025	0.00173	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—CNR1—epilepsy syndrome	0.000247	0.00171	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—GRM4—epilepsy syndrome	0.000245	0.0017	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—GRM3—epilepsy syndrome	0.000245	0.0017	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—OPRD1—epilepsy syndrome	0.000244	0.00169	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—SSTR2—epilepsy syndrome	0.000241	0.00167	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—HTR7—epilepsy syndrome	0.000241	0.00167	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CHRM1—epilepsy syndrome	0.000234	0.00162	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CCR7—epilepsy syndrome	0.000234	0.00162	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—GRM1—epilepsy syndrome	0.000234	0.00162	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—PDYN—epilepsy syndrome	0.000234	0.00162	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—GRM8—epilepsy syndrome	0.000233	0.00161	CbGpPWpGaD
Emedastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.000226	0.00157	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—ACKR4—epilepsy syndrome	0.000225	0.00156	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—OPRD1—epilepsy syndrome	0.000222	0.00154	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—GNAO1—epilepsy syndrome	0.000222	0.00154	CbGpPWpGaD
Emedastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.000221	0.00153	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—GAL—epilepsy syndrome	0.00022	0.00153	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—GRM5—epilepsy syndrome	0.000218	0.00151	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.000218	0.00151	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CCR7—epilepsy syndrome	0.000213	0.00147	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CHRM1—epilepsy syndrome	0.000213	0.00147	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—GRM1—epilepsy syndrome	0.000213	0.00147	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—PDYN—epilepsy syndrome	0.000213	0.00147	CbGpPWpGaD
Emedastine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.00021	0.00145	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.000205	0.00142	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.000205	0.00142	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—SSTR4—epilepsy syndrome	0.000204	0.00141	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—SSTR5—epilepsy syndrome	0.000204	0.00141	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—AVP—epilepsy syndrome	0.000203	0.0014	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—GAL—epilepsy syndrome	0.0002	0.00139	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.000199	0.00138	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—GRM5—epilepsy syndrome	0.000198	0.00137	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000198	0.00137	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CCR10—epilepsy syndrome	0.000195	0.00135	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000191	0.00132	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.00019	0.00131	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.000188	0.0013	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000186	0.00129	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000186	0.00129	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000186	0.00129	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000181	0.00125	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000178	0.00123	CbGpPWpGaD
Emedastine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000177	0.00122	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—HRH3—epilepsy syndrome	0.000174	0.0012	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—NPY—epilepsy syndrome	0.000173	0.0012	CbGpPWpGaD
Emedastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000173	0.0012	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—CCR5—epilepsy syndrome	0.000172	0.00119	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000171	0.00118	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—GRM2—epilepsy syndrome	0.000171	0.00118	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000169	0.00117	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000167	0.00116	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CRH—epilepsy syndrome	0.000167	0.00116	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—OXT—epilepsy syndrome	0.000167	0.00116	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CCR3—epilepsy syndrome	0.000161	0.00112	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—AGT—epilepsy syndrome	0.00016	0.00111	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—NPY—epilepsy syndrome	0.000157	0.00109	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—SSTR3—epilepsy syndrome	0.000154	0.00107	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—OXT—epilepsy syndrome	0.000152	0.00105	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CRH—epilepsy syndrome	0.000152	0.00105	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000152	0.00105	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CCL3—epilepsy syndrome	0.000152	0.00105	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000151	0.00105	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—SST—epilepsy syndrome	0.000151	0.00105	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000151	0.00105	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000148	0.00102	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—NPY2R—epilepsy syndrome	0.000148	0.00102	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—SSTR1—epilepsy syndrome	0.000148	0.00102	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CCR9—epilepsy syndrome	0.000148	0.00102	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CCR8—epilepsy syndrome	0.000148	0.00102	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000148	0.00102	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—GRM4—epilepsy syndrome	0.000145	0.001	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—GRM3—epilepsy syndrome	0.000145	0.001	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—DUSP4—epilepsy syndrome	0.000142	0.000986	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—SSTR2—epilepsy syndrome	0.000142	0.000986	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000142	0.000983	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000142	0.000983	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000139	0.000965	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000139	0.000962	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—GRM8—epilepsy syndrome	0.000137	0.000952	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—PGF—epilepsy syndrome	0.000137	0.000952	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CCR2—epilepsy syndrome	0.000137	0.00095	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—SST—epilepsy syndrome	0.000137	0.00095	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000136	0.000942	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—POMC—epilepsy syndrome	0.000135	0.000932	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000134	0.000929	CbGpPWpGaD
Emedastine—HRH1—GPCR ligand binding—CCL2—epilepsy syndrome	0.000132	0.000912	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—GNAO1—epilepsy syndrome	0.000131	0.000908	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—OPRD1—epilepsy syndrome	0.000131	0.000908	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—AKT3—epilepsy syndrome	0.00013	0.000897	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000129	0.000893	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000129	0.000893	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CNR1—epilepsy syndrome	0.000127	0.000876	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000126	0.000873	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—PDYN—epilepsy syndrome	0.000126	0.000871	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—GRM1—epilepsy syndrome	0.000126	0.000871	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CCR7—epilepsy syndrome	0.000126	0.000871	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CHRM1—epilepsy syndrome	0.000126	0.000871	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—HTR7—epilepsy syndrome	0.000123	0.000855	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—HBEGF—epilepsy syndrome	0.00012	0.00083	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000118	0.000819	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—GFAP—epilepsy syndrome	0.000118	0.000819	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—GAL—epilepsy syndrome	0.000118	0.000819	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—AKT3—epilepsy syndrome	0.000118	0.000815	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—GRM5—epilepsy syndrome	0.000117	0.000809	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CASP2—epilepsy syndrome	0.000117	0.000809	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CHRM3—epilepsy syndrome	0.000117	0.000809	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	0.000114	0.000793	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000112	0.000776	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	0.00011	0.000761	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	0.00011	0.000761	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	0.00011	0.000761	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	0.000107	0.000743	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	0.000107	0.00074	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	0.000104	0.00072	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	0.000102	0.00071	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	0.000101	0.000699	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	9.73e-05	0.000674	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	9.53e-05	0.00066	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	9.52e-05	0.000659	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—NPY—epilepsy syndrome	9.29e-05	0.000643	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	9.29e-05	0.000643	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	9.04e-05	0.000626	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	8.96e-05	0.00062	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	8.96e-05	0.00062	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CRH—epilepsy syndrome	8.96e-05	0.00062	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	8.96e-05	0.00062	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—OXT—epilepsy syndrome	8.96e-05	0.00062	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	8.84e-05	0.000612	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	8.65e-05	0.000599	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.35e-05	0.000578	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	8.33e-05	0.000577	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	8.33e-05	0.000577	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	8.21e-05	0.000568	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	8.1e-05	0.000561	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	8.1e-05	0.000561	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—SST—epilepsy syndrome	8.1e-05	0.000561	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	8.03e-05	0.000556	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	7.93e-05	0.000549	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	7.9e-05	0.000547	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	7.62e-05	0.000527	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	7.62e-05	0.000527	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	7.61e-05	0.000527	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	7.58e-05	0.000525	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	7.55e-05	0.000523	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	7.48e-05	0.000518	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	7.48e-05	0.000518	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	7.45e-05	0.000516	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	7.3e-05	0.000505	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	7.08e-05	0.00049	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	6.95e-05	0.000481	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	6.91e-05	0.000478	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	6.79e-05	0.00047	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	6.76e-05	0.000468	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	6.42e-05	0.000445	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	6.36e-05	0.00044	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	6.34e-05	0.000439	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	6.14e-05	0.000425	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	5.81e-05	0.000402	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	5.65e-05	0.000391	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	5.63e-05	0.00039	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	5.62e-05	0.000389	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.43e-05	0.000376	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	5.37e-05	0.000372	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	5.22e-05	0.000361	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	5.11e-05	0.000354	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	4.85e-05	0.000336	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	4.85e-05	0.000336	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	4.75e-05	0.000329	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	4.65e-05	0.000322	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	4.48e-05	0.00031	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	4.46e-05	0.000309	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	4.08e-05	0.000283	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	3.99e-05	0.000276	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	3.61e-05	0.00025	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	3.35e-05	0.000232	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	3.28e-05	0.000227	CbGpPWpGaD
Emedastine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.05e-05	0.000211	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	3.02e-05	0.000209	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	2.93e-05	0.000203	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	2.86e-05	0.000198	CbGpPWpGaD
Emedastine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	2.77e-05	0.000192	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	2.63e-05	0.000182	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	2.56e-05	0.000178	CbGpPWpGaD
Emedastine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.64e-05	0.000113	CbGpPWpGaD
